Citations 1
Phase I trial of ontuxizumab (MORAb-004) in children with relapsed or refractory solid tumors: A Children’s Oncology Group Study.
Norris, Robin E. , Fox, Elizabeth , Ralya, Andrew T., Liu, Xiaowei , Ahern, Charlotte H., Dahl, Jodell, Eubank, Rachel, Weigel, Brenda J. , Reid, Joel M. , Minard, Charles G.
Journal of Clinical Oncology | April 19, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 10036-10036
